Integral Health Asset Management as of Dec. 31, 2021
Portfolio Holdings for Integral Health Asset Management
Integral Health Asset Management holds 71 positions in its portfolio as reported in the December 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Centene Corporation (CNC) | 5.1 | $19M | 225k | 82.40 | |
Sage Therapeutics (SAGE) | 4.8 | $17M | 409k | 42.54 | |
Cytokinetics Com New (CYTK) | 4.1 | $15M | 325k | 45.58 | |
PerkinElmer (RVTY) | 3.9 | $14M | 70k | 201.06 | |
McKesson Corporation (MCK) | 3.8 | $14M | 55k | 248.56 | |
Envista Hldgs Corp (NVST) | 3.7 | $14M | 300k | 45.06 | |
Globus Med Cl A (GMED) | 3.6 | $13M | 180k | 72.20 | |
Pfizer (PFE) | 3.3 | $12M | 200k | 59.05 | |
Anthem (ELV) | 3.2 | $12M | 25k | 463.56 | |
Zentalis Pharmaceuticals (ZNTL) | 2.8 | $10M | 120k | 84.06 | |
Abbott Laboratories (ABT) | 2.7 | $9.9M | 70k | 140.74 | |
CVS Caremark Corporation (CVS) | 2.4 | $8.8M | 85k | 103.16 | |
Biogen Idec (BIIB) | 2.3 | $8.4M | 35k | 239.91 | |
Amedisys (AMED) | 2.2 | $8.1M | 50k | 161.88 | |
Blueprint Medicines (BPMC) | 2.2 | $8.0M | 75k | 107.11 | |
Fate Therapeutics (FATE) | 2.1 | $7.6M | 130k | 58.51 | |
Acadia Healthcare (ACHC) | 2.0 | $7.3M | 120k | 60.70 | |
Chemocentryx | 2.0 | $7.3M | 200k | 36.41 | |
Relay Therapeutics (RLAY) | 1.9 | $6.9M | 225k | 30.71 | |
Heron Therapeutics (HRTX) | 1.9 | $6.8M | 750k | 9.13 | |
Abbvie (ABBV) | 1.9 | $6.8M | 50k | 135.40 | |
Tenet Healthcare Corp Com New (THC) | 1.8 | $6.5M | 80k | 81.69 | |
Laboratory Corp Amer Hldgs Com New | 1.7 | $6.3M | 20k | 314.20 | |
Intellia Therapeutics (NTLA) | 1.6 | $5.9M | 50k | 118.24 | |
Edwards Lifesciences (EW) | 1.6 | $5.8M | 45k | 129.56 | |
Astrazeneca Sponsored Adr (AZN) | 1.6 | $5.8M | 100k | 58.25 | |
Apellis Pharmaceuticals (APLS) | 1.6 | $5.7M | 120k | 47.28 | |
1life Healthcare | 1.3 | $4.8M | 275k | 17.57 | |
Irhythm Technologies (IRTC) | 1.3 | $4.7M | 40k | 117.70 | |
Denali Therapeutics (DNLI) | 1.2 | $4.5M | 100k | 44.60 | |
Glaxosmithkline Sponsored Adr | 1.2 | $4.4M | 100k | 44.10 | |
BioMarin Pharmaceutical (BMRN) | 1.2 | $4.2M | 48k | 88.35 | |
Si-bone (SIBN) | 1.1 | $3.9M | 175k | 22.21 | |
Alnylam Pharmaceuticals (ALNY) | 0.9 | $3.4M | 20k | 169.60 | |
Agilon Health (AGL) | 0.9 | $3.4M | 125k | 27.00 | |
Arrowhead Pharmaceuticals (ARWR) | 0.9 | $3.3M | 50k | 66.30 | |
Horizon Therapeutics Pub L SHS | 0.9 | $3.2M | 30k | 107.77 | |
Atara Biotherapeutics | 0.9 | $3.2M | 200k | 15.76 | |
Masimo Corporation (MASI) | 0.8 | $2.9M | 10k | 292.80 | |
Aclaris Therapeutics (ACRS) | 0.8 | $2.9M | 200k | 14.54 | |
Nevro (NVRO) | 0.8 | $2.8M | 35k | 81.06 | |
Avalo Therapeutics | 0.8 | $2.8M | 1.6M | 1.70 | |
Reata Pharmaceuticals Cl A | 0.8 | $2.7M | 103k | 26.37 | |
Replimune Group (REPL) | 0.7 | $2.7M | 100k | 27.10 | |
Bridgebio Pharma Call Call Option | 0.7 | $2.5M | 150k | 16.68 | |
Regenxbio Inc equity us cm (RGNX) | 0.7 | $2.5M | 75k | 32.71 | |
Arcturus Therapeutics Hldg I (ARCT) | 0.7 | $2.4M | 65k | 37.02 | |
Iteos Therapeutics (ITOS) | 0.6 | $2.3M | 50k | 46.56 | |
Incyte Corporation (INCY) | 0.6 | $2.2M | 30k | 73.40 | |
Insmed Com Par $.01 (INSM) | 0.6 | $2.2M | 80k | 27.24 | |
Macrogenics (MGNX) | 0.6 | $2.1M | 130k | 16.05 | |
Uniqure Nv SHS (QURE) | 0.6 | $2.1M | 100k | 20.74 | |
Keros Therapeutics (KROS) | 0.6 | $2.0M | 35k | 58.51 | |
Amicus Therapeutics (FOLD) | 0.6 | $2.0M | 175k | 11.55 | |
ImmunoGen | 0.5 | $1.9M | 250k | 7.42 | |
Akero Therapeutics (AKRO) | 0.5 | $1.8M | 85k | 21.15 | |
Ptc Therapeutics I (PTCT) | 0.5 | $1.8M | 45k | 39.82 | |
Kiniksa Pharmaceuticals Com Cl A | 0.5 | $1.6M | 140k | 11.77 | |
Mirum Pharmaceuticals (MIRM) | 0.4 | $1.6M | 100k | 15.95 | |
Precision Biosciences Ord | 0.4 | $1.3M | 175k | 7.40 | |
Intercept Pharmaceuticals In | 0.3 | $1.2M | 75k | 16.29 | |
Kura Oncology (KURA) | 0.3 | $1.2M | 85k | 14.00 | |
Alkermes SHS (ALKS) | 0.3 | $1.2M | 50k | 23.26 | |
Lyell Immunopharma (LYEL) | 0.3 | $1.1M | 140k | 7.74 | |
Forma Therapeutics Hldgs SHS | 0.3 | $1.1M | 75k | 14.23 | |
Lexicon Pharmaceuticals Com New (LXRX) | 0.2 | $788k | 200k | 3.94 | |
Chimerix (CMRX) | 0.2 | $707k | 110k | 6.43 | |
Amarin Corp Spons Adr New (AMRN) | 0.2 | $674k | 200k | 3.37 | |
Magenta Therapeutics | 0.1 | $399k | 90k | 4.43 | |
Myovant Sciences | 0.1 | $389k | 25k | 15.56 | |
Longboard Pharmaceuticals In (LBPH) | 0.0 | $146k | 30k | 4.87 |